Anardi Agosto-Mujica
Allergy & Immunology · Cayey, PRNPI 1215901426
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $30,761 of the $42,137 with a category attached, or 73.0%. Pharming Healthcare, Inc. accounts for 72.5% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2024 at $29,150 and has fallen 96.4% since, to $1,043 in 2025.
Across 356 payments — averaging $118.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharming Healthcare, Inc.$31K
- Sanofi$3K
- AbbVie$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Biocryst US Sales Co., LLC$1K
- AstraZeneca$1K
- plus $2K from 18 others
Across 28 payments — averaging $377.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$11K
What the payments were for
- Consulting fees$30,76173%
- Travel & lodging$3,0857%
- Food & beverage$8,20119%
- Education$900%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pharming Healthcare, Inc. | 30 | $30,550 |
| Sanofi | 52 | $3,317 |
| AbbVie | 8 | $1,877 |
| Takeda Pharmaceuticals U.S.A., Inc. | 90 | $1,731 |
| Biocryst US Sales Co., LLC | 51 | $1,263 |
| AstraZeneca | 49 | $1,206 |
| Medtronic | 2 | $511 |
| GSK | 14 | $369 |
| PBG Puerto Rico LLC | 17 | $343 |
| Shire North American Group Inc | 12 | $130 |
| Amgen | 5 | $120 |
| Eli Lilly Export S.A. Puerto Rico Branch | 3 | $115 |
| Abbott | 6 | $115 |
| Sanofi-aventis U.S. LLC | 4 | $114 |
| Merck | 1 | $96 |
| Pfizer | 2 | $50 |
| Novartis | 2 | $45 |
| LEO Pharma Inc. | 2 | $42 |
| CSL Behring | 1 | $39 |
| Mylan Specialty L.p. | 1 | $27 |
| Genentech USA, Inc. | 1 | $24 |
| Boston Scientific | 1 | $19 |
| Radius Health, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JOENJA$30,073
- DUPIXENT$1,946
- Rinvoq$1,725
- Minimed 670G System$414
- CUVITRU$122
- TRELEGY ELLIPTA$117
- RUCONEST$114
- TEZSPIRE$100
How this compares
$42,137 in reported general payments places this provider in the 85th percentile of 25 allergy & immunology providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TakhzyroLanadelumab-Flyo | 11 | $569,074 |
| OrladeyoBerotralstat Hydrochloride | 12 | $524,657 |
| Dupixent SyringeDupilumab | 64 | $241,549 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 275 | $181,651 |
| XolairOmalizumab | 66 | $175,021 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 19 | $90,007 |
| Dupixent PenDupilumab | 19 | $72,391 |
| NucalaMepolizumab | 20 | $69,428 |
| Epinephrine | 104 | $30,284 |
| OzempicSemaglutide | 28 | $27,477 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 34 | $23,309 |
| Breo ElliptaFluticasone/Vilanterol | 44 | $18,130 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 51 | $13,567 |
| Fluticasone Propionate | 672 | $11,839 |
| Arnuity ElliptaFluticasone Furoate | 48 | $11,726 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Takhzyro | $1,731 | $569,07411 claims |
| Biocryst US Sales Co., LLCOrladeyo | $1,263 | $524,65712 claims |
| GSKTrelegy Ellipta, Nucala, Breo Ellipta, Arnuity Ellipta | $369 | $280,935387 claims |
| CSL BehringPrivigen | $39 | $90,00719 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,206 | $27,35648 claims |
| AbbVieSynthroid | $1,877 | $4,62246 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 25 allergy & immunology providers in Puerto Rico.
Other allergy & immunology in Cayey
- Cristina RamosSan Juan$441K
- Jose MorenoSan Juan$93K
- Wilfredo Cosme BlancoAguadilla$53K
- Erving Arroyo FloresBayamon$6K
- Giannina Coppola-FasickCarolina$5K
- Veronica Diaz VidalCaguas$5K
- Jose Zaragoza BuxoArecibo$4K
- Sybelle Serrano SantiagoHato Rey$4K
- Yanira Benitez OrtizSan Juan$4K
- Nicole Sosa CastellanosCarolina$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.